Freedom Holding Corp. Reports Third Quarter Fiscal Year 2024 Financial Results
With
-
$419 million in revenue -
Net income of
$96 million , or$1.63 earnings per share, diluted -
Operating expenses of
$307 million -
177% increase in insurance underwriting premiums to approximately
$79 million -
New branch offices now include
Italy ,The Netherlands ,Austria , andBulgaria
Third Quarter Financial Highlights:
The Company recognized revenue of approximately
Net income was approximately
Nine Months Year to Date Financial Highlights:
For the nine months ending
Net income was approximately
Balance Sheet Highlights:
Total assets were
Brokerage Customer Information:
Total brokerage customer count for the Company increased to approximately 458,000 at
"Our Central Asia and Eastern European business lead the way for growth…"
Commenting on the quarterly results, Timur Turlov, the Company's founder and chief executive officer, stated, "Our fiscal year 2024 has been excellent thus far, highlighted by the planned diversification of our revenue streams and the healthy expansion of almost all business lines in each of our regions. Central Asian operations (
"Our Central Asia and Eastern European business lead the way for growth for our enterprise, which includes our
"Our operating expenses grew in line with our strategic expansion…"
In the third quarter of fiscal 2024,
"Highlighted by
Additional select third quarter fiscal 2024 highlights:
Similar to the preceding quarter ended
The Company realized a net loss from securities trading of approximately
Fee and commission income rose by 49% to approximately
About
To learn more about
Cautionary Note Regarding Forward-Looking Statements
This release contains "forward-looking" statements, including with respect to
Website Disclosure
Financial Tables to Follow
|
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) |
|||||
|
(All amounts in thousands of |
|||||
|
|
|
||||
|
ASSETS |
|
|
|
||
|
Cash and cash equivalents |
561,883 |
|
|
581,417 |
|
|
Restricted cash |
384,553 |
|
|
445,528 |
|
|
Trading securities |
3,680,453 |
|
|
2,412,556 |
|
|
Available-for-sale securities, at fair value |
202,497 |
|
|
239,053 |
|
|
Margin lending, brokerage and other receivables, net |
961,392 |
|
|
376,329 |
|
|
Loans issued |
1,346,005 |
|
|
826,258 |
|
|
Fixed assets, net |
78,099 |
|
|
54,017 |
|
|
Intangible assets, net |
46,771 |
|
|
17,615 |
|
|
|
52,238 |
|
|
14,192 |
|
|
Right-of-use asset |
34,180 |
|
|
30,345 |
|
|
Insurance contract assets |
12,728 |
|
|
13,785 |
|
|
Other assets, net |
88,244 |
|
|
73,463 |
|
|
TOTAL ASSETS |
7,449,043 |
|
|
5,084,558 |
|
|
|
|
|
|
||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
||
|
Securities repurchase agreement obligations |
2,889,173 |
|
|
1,517,416 |
|
|
Customer liabilities |
2,248,042 |
|
|
1,925,247 |
|
|
Margin lending and trade payables |
145,804 |
|
|
122,900 |
|
|
Liabilities from insurance activity |
242,179 |
|
|
182,502 |
|
|
Current income tax liability |
27,711 |
|
|
4,547 |
|
|
Debt securities issued |
266,310 |
|
|
60,025 |
|
|
Lease liability |
34,614 |
|
|
30,320 |
|
|
Liability arising from continuing involvement |
494,513 |
|
|
440,805 |
|
|
Other liabilities |
61,447 |
|
|
30,060 |
|
|
TOTAL LIABILITIES |
6,409,793 |
|
|
4,313,822 |
|
|
|
|
|
|
||
|
SHAREHOLDERS’ EQUITY |
|
|
|
||
|
Preferred stock |
- |
|
|
- |
|
|
Common stock |
59 |
|
|
59 |
|
|
Additional paid in capital |
167,465 |
|
|
164,162 |
|
|
Retained earnings |
903,517 |
|
|
647,064 |
|
|
Accumulated other comprehensive loss |
(34,845 |
) |
|
(34,000 |
) |
|
|
|
|
|
||
|
TOTAL FRHC SHAREHOLDERS' EQUITY |
1,036,196 |
|
|
777,285 |
|
|
|
|
|
|
||
|
Noncontrolling interest |
3,054 |
|
|
(6,549 |
) |
|
TOTAL SHAREHOLDERS’ EQUITY |
1,039,250 |
|
|
770,736 |
|
|
|
|
|
|
||
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
7,449,043 |
|
|
5,084,558 |
|
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND STATEMENTS OF OTHER |
||||||||
|
COMPREHENSIVE INCOME (Unaudited) |
||||||||
|
(All amounts in thousands of |
||||||||
|
|
Three months ended |
Nine months ended |
||||||
|
2023 |
2022 |
2023 |
2022 |
|||||
|
Revenue: |
|
|
|
|
||||
|
Fee and commission income |
120,159 |
|
80,883 |
|
330,565 |
|
253,486 |
|
|
Net (loss)/gain on financial instruments through profit and loss |
(5,089 |
) |
25,456 |
|
77,498 |
|
38,894 |
|
|
Interest income |
226,445 |
|
80,255 |
|
588,857 |
|
187,817 |
|
|
Insurance underwriting income |
79,017 |
|
28,557 |
|
181,882 |
|
78,998 |
|
|
Net gain on foreign exchange operations |
38,825 |
|
20,866 |
|
54,430 |
|
30,014 |
|
|
Net loss on derivative |
(42,568 |
) |
(21,469 |
) |
(71,795 |
) |
(22,523 |
) |
|
Other income/ (expense) |
1,845 |
|
(570 |
) |
8,988 |
|
(79 |
) |
|
|
|
|
|
|
||||
|
TOTAL REVENUE, NET |
418,634 |
|
213,978 |
|
1,170,425 |
|
566,607 |
|
|
|
|
|
|
|
||||
|
Expense: |
|
|
|
|
||||
|
Fee and commission expense |
42,818 |
|
18,314 |
|
103,116 |
|
60,068 |
|
|
Interest expense |
131,223 |
|
52,037 |
|
365,650 |
|
132,971 |
|
|
|
|
|
|
|
||||
|
Insurance claims incurred, net of reinsurance |
40,989 |
|
17,419 |
|
96,491 |
|
51,586 |
|
|
Payroll and bonuses |
45,083 |
|
21,610 |
|
116,711 |
|
55,252 |
|
|
Professional services |
6,217 |
|
5,901 |
|
24,793 |
|
14,174 |
|
|
Stock compensation expense |
1,039 |
|
2,939 |
|
3,303 |
|
6,519 |
|
|
Advertising expense |
11,066 |
|
3,730 |
|
27,805 |
|
9,479 |
|
|
General and administrative expense |
32,106 |
|
16,428 |
|
86,211 |
|
40,943 |
|
|
(Recovery)/Allowance for expected credit losses |
(3,526 |
) |
24,140 |
|
15,462 |
|
30,294 |
|
|
|
|
|
|
|
||||
|
TOTAL EXPENSE |
307,015 |
|
162,518 |
|
839,542 |
|
401,286 |
|
|
|
|
|
|
|
||||
|
INCOME BEFORE INCOME TAX |
111,619 |
|
51,460 |
|
330,883 |
|
165,321 |
|
|
|
|
|
|
|
||||
|
Income tax expense |
(15,544 |
) |
(5,069 |
) |
(51,408 |
) |
(26,567 |
) |
|
|
|
|
|
|
||||
|
INCOME FROM CONTINUING OPERATIONS |
96,075 |
|
46,391 |
|
279,475 |
|
138,754 |
|
|
|
|
|
|
|
||||
|
INCOME BEFORE INCOME TAX EXPENSE OF DISCONTINUED OPERATION |
- |
|
13,667 |
|
- |
|
14,467 |
|
|
|
|
|
|
|
||||
|
Income tax benefit/(expense) of discontinued operations |
- |
|
2,342 |
|
- |
|
(4,538 |
) |
|
|
|
|
|
|
||||
|
INCOME FROM DISCONTINUED OPERATIONS |
- |
|
16,009 |
|
- |
|
9,929 |
|
|
|
|
|
|
|
||||
|
NET INCOME |
96,075 |
|
62,400 |
|
279,475 |
|
148,683 |
|
|
|
|
|
|
|
||||
|
Less: Net loss attributable to noncontrolling interest in subsidiary |
(293 |
) |
(464 |
) |
(842 |
) |
(1,508 |
) |
|
|
|
|
|
|
||||
|
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS |
96,368 |
|
62,864 |
|
280,317 |
|
150,191 |
|
|
|
|
|
|
|
||||
|
OTHER COMPREHENSIVE INCOME |
|
|
|
|
||||
|
Change in unrealized gain/(loss) on investments available-for-sale, net of tax effect |
1,486 |
|
(54 |
) |
5,893 |
|
2,309 |
|
|
Reclassification adjustment for net realized (loss)/gain on available-for-sale investments disposed of in the period, net of tax effect |
(1,881 |
) |
320 |
|
(3,145 |
) |
197 |
|
|
Foreign currency translation adjustments |
28,100 |
|
(5,611 |
) |
(3,593 |
) |
(301 |
) |
|
OTHER COMPREHENSIVE INCOME/(LOSS) |
27,705 |
|
(5,345 |
) |
(845 |
) |
2,205 |
|
|
|
|
|
|
|
||||
|
COMPREHENSIVE INCOME BEFORE NONCONTROLLING INTERESTS |
123,780 |
|
57,055 |
|
278,630 |
|
150,888 |
|
|
|
|
|
|
|
||||
|
Less: Comprehensive loss attributable to noncontrolling interest in subsidiary |
(293 |
) |
(464 |
) |
(842 |
) |
(1,508 |
) |
|
|
|
|
|
|
||||
|
COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS |
124,073 |
|
57,519 |
|
279,472 |
|
152,396 |
|
|
|
|
|
|
|
||||
|
EARNINGS PER COMMON SHARE (In |
|
|
|
|
||||
|
Earnings from continuing operations per common share - basic (Restated) |
1.65 |
|
0.79 |
|
4.79 |
|
2.37 |
|
|
Earnings from continuing operations per common share - diluted (Restated) |
1.63 |
|
0.78 |
|
4.73 |
|
2.33 |
|
|
|
|
|
|
|
||||
|
Earnings/(loss) from discontinued operations per common share - basic |
- |
|
0.27 |
|
- |
|
0.17 |
|
|
Earnings/(loss) from discontinued operations per common share - diluted |
- |
|
0.27 |
|
- |
|
0.17 |
|
|
|
|
|
|
|
||||
|
Earnings per common share - basic (Restated) |
1.65 |
|
1.06 |
|
4.79 |
|
2.54 |
|
|
Earnings per common share - diluted (Restated) |
1.63 |
|
1.05 |
|
4.73 |
|
2.50 |
|
|
|
|
|
|
|
||||
|
Weighted average number of shares (basic) |
58,578,691 |
|
58,678,730 |
|
58,557,577 |
|
58,642,637 |
|
|
Weighted average number of shares (diluted) |
59,289,256 |
|
59,522,701 |
|
59,287,086 |
|
59,527,743 |
|
src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20240212551579r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />
View source version on businesswire.com: https://www.businesswire.com/news/home/20240212551579/en/
Ramina Fakhrutdinova (KZ)
Public Relations
Freedom Finance JSC
+7 777 377 8868
pr@ffin.kz
Freedom US Markets
+1 212-980-4400, Ext. 1013
apalombo@freedomusmkts.com
Source:


NY healthcare advocates call on Gov. Hochul to close Medicaid funding gap
With PENNCREST union agreement, local districts set until 2026-27 [The Meadville Tribune, Pa.]
Advisor News
- CT governor’s candidates claims: What’s true, and what’s misleading
- Retaining clients by giving them a memorable experience
- Addressing the longevity paradox
- Employers shift focus from retirement access to financial outcomes
- Helping widowed clients navigate their new financial reality
More Advisor NewsAnnuity News
- National Life Group expands annuity portfolio
- AM Best to Join Life/Annuity Insurance-Focused Panel Discussion at Capitol Forum Event
- USAA Earns No. 1 Ranking in JD Power Individual Annuity Study for the Third Consecutive Year
- How flexible annuities fit today’s retirement portfolios
- Foresters Financial appoints Tom Ross as chief distribution officer for U.S. annuity sales
More Annuity NewsHealth/Employee Benefits News
- Reports Outline OBGYN and Reproduction Study Findings from Health Care Cost Institute (Hospital Bypass Among Rural Obstetric Patients With Commercial Health Insurance): OBGYN and Reproduction
- Madison Faces Higher Library and Health Insurance Costs as Officials Look Ahead to 2027 Budget
- The percentage of people without health insurance is growing
- MORE THAN 4 MILLION MEDICARE BENEFICIARIES WILL HAVE THEIR MEDICARE ADVANTAGE OR STAND-ALONE PRESCRIPTION DRUG PLAN TERMINATED AT THE END OF 2026
- Plans with cheaper premiums are risky business for Americans seeking lower healthcare costs
More Health/Employee Benefits NewsLife Insurance News